TD Capital Management’s Prothena Corp PRTA Stock Holding History

TD Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	281
2021 Q4	$0	Hold	1	–	–	﹤0.01%	391
2021 Q3	$0	Hold	1	–	–	﹤0.01%	375
2021 Q2	$0	Buy	+1	New	+$31	﹤0.01%	356

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TD Capital Management's PRTA Position: Q1 2022 in Review

TD Capital Management sold out of Prothena Corp (PRTA) in Q1 2022, closing a stake of 1 share.

TD Capital Management first reported a position in PRTA in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q4 2021. 174 funds tracked by Wall St. Rank hold PRTA as of Q1 2022.

TD Capital Management reported no remaining Prothena Corp position as of Q1 2022 after selling out during the quarter.
TD Capital Management sold 1 Prothena Corp share in Q1 2022.
TD Capital Management first reported a position in Prothena Corp in Q2 2021 and held it in 3 quarters.
TD Capital Management's Prothena Corp position peaked at $0 in Q4 2021.
174 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2022.

Based on TD Capital Management's 13F filing for Q1 2022, filed 18 May 2022.